Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Scheinberg

Showing results (291-300 of 426) with videos related to

Pageof 43
Sort By:
Leukemia|September 23, 2006
Improved human T-cell responses against synthetic HLA-0201 analog peptides derived from the WT1 oncoproteinJ Pinilla-Ibarz, R J May, T Korontsvit, et al.
Leukemia|February 13, 2002
Radioimmunotherapy for model B cell malignancies using 90Y-labeled anti-CD19 and anti-CD20 monoclonal antibodiesD Ma, M R McDevitt, E Barendswaard, et al.
Blood|January 25, 1992
Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemiaJ Muindi, S R Frankel, W H Miller, et al.
Revista Do Instituto De Medicina Tropical De Sao Paulo|March 1, 1996
Immunological status of ENL (erythema nodosum leprosum) patients: its relationship to bacterial load and levels of circulating IL-2RL M Vieira, E P Sampaio, J A Nery, et al.
Annals of the Rheumatic Diseases|April 22, 2014
A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC studyR A Furie, G Leon, M Thomas, et al.
Physics in Medicine and Biology|January 12, 2011
Renal uptake of bismuth-213 and its contribution to kidney radiation dose following administration of actinium-225-labeled antibodyJ Schwartz, J S Jaggi, J A O'Donoghue, et al.
Journal of Clinical Immunology|January 1, 1994
Antimitochondrial (pyruvate dehydrogenase) antibodies in leprosyB Gilburd, L Ziporen, D Zharhary, et al.
Blood|April 12, 2014
A TCR-mimic antibody to WT1 bypasses tyrosine kinase inhibitor resistance in human BCR-ABL+ leukemiasLeonid Dubrovsky, Dmitry Pankov, Elliott Joseph Brea, et al.
Scientific Reports|January 9, 2021
Fibrillar pharmacology of functionalized nanocelluloseSam Wong, Simone Alidori, Barbara P Mello, et al.
Plos One|August 29, 2017
Carbon nanotubes exhibit fibrillar pharmacology in primatesSimone Alidori, Daniel L J Thorek, Bradley J Beattie, et al.
Pageof 43

Showing results (291-300 of 426) with videos related to

Sort By:
Pageof 43
Leukemia|September 23, 2006
Improved human T-cell responses against synthetic HLA-0201 analog peptides derived from the WT1 oncoproteinJ Pinilla-Ibarz, R J May, T Korontsvit, et al.
Leukemia|February 13, 2002
Radioimmunotherapy for model B cell malignancies using 90Y-labeled anti-CD19 and anti-CD20 monoclonal antibodiesD Ma, M R McDevitt, E Barendswaard, et al.
Blood|January 25, 1992
Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemiaJ Muindi, S R Frankel, W H Miller, et al.
Revista Do Instituto De Medicina Tropical De Sao Paulo|March 1, 1996
Immunological status of ENL (erythema nodosum leprosum) patients: its relationship to bacterial load and levels of circulating IL-2RL M Vieira, E P Sampaio, J A Nery, et al.
Annals of the Rheumatic Diseases|April 22, 2014
A phase 2, randomised, placebo-controlled clinical trial of blisibimod, an inhibitor of B cell activating factor, in patients with moderate-to-severe systemic lupus erythematosus, the PEARL-SC studyR A Furie, G Leon, M Thomas, et al.
Physics in Medicine and Biology|January 12, 2011
Renal uptake of bismuth-213 and its contribution to kidney radiation dose following administration of actinium-225-labeled antibodyJ Schwartz, J S Jaggi, J A O'Donoghue, et al.
Journal of Clinical Immunology|January 1, 1994
Antimitochondrial (pyruvate dehydrogenase) antibodies in leprosyB Gilburd, L Ziporen, D Zharhary, et al.
Blood|April 12, 2014
A TCR-mimic antibody to WT1 bypasses tyrosine kinase inhibitor resistance in human BCR-ABL+ leukemiasLeonid Dubrovsky, Dmitry Pankov, Elliott Joseph Brea, et al.
Scientific Reports|January 9, 2021
Fibrillar pharmacology of functionalized nanocelluloseSam Wong, Simone Alidori, Barbara P Mello, et al.
Plos One|August 29, 2017
Carbon nanotubes exhibit fibrillar pharmacology in primatesSimone Alidori, Daniel L J Thorek, Bradley J Beattie, et al.
Pageof 43